首页 › 基金 › TPG GP A, LLC › AMRX
TPG GP A, LLC 对 AMRX 的持仓历史
AMNEAL PHARMACEUTICALS INC · 医疗保健
TPG GP A, LLC 在 Q2 2026 的 13F 申报中披露持有 AMRX(AMNEAL PHARMACEUTICALS INC)12,328,767 股,市值约 US$213.4M,约占其申报组合的 4.39%,在其申报持仓中市值排名第 7 位。 TPG GP A, LLC 最近 12 个申报季度中有 12 个季度披露了 AMRX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
TPG GP A, LLC 对 AMRX 的持仓演变
TPG GP A, LLC 于 Q3 2023 首次披露 AMRX 持仓:12,328,767 股(约 US$52.0M)。 该持仓在 Q2 2026 达到峰值 12,328,767 股,市值约 US$213.4M。 在 12 次申报中,TPG GP A, LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 12,328,767 股、市值约 US$213.4M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 12.33M | $52.03M | 新进 |
| Q4 2023 | 12.33M | $74.84M | 持有 |
| Q1 2024 | 12.33M | $74.71M | 持有 |
| Q2 2024 | 12.33M | $78.29M | 持有 |
| Q3 2024 | 12.33M | $102.58M | 持有 |
| Q4 2024 | 12.33M | $97.64M | 持有 |
| Q1 2025 | 12.33M | $103.32M | 持有 |
| Q2 2025 | 12.33M | $99.74M | 持有 |
| Q3 2025 | 12.33M | $123.41M | 持有 |
| Q4 2025 | 12.33M | $155.34M | 持有 |
| Q1 2026 | 12.33M | $153.25M | 持有 |
| Q2 2026 | 12.33M | $213.41M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AMRX 与 13F 数据
AMRX(AMNEAL PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 AMRX,申报仓位最大的包括:Rubric Capital Management LP (US$176.0M), Nantahala Capital Management, LLC (US$39.3M), Westshore Wealth, LLC (US$23.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AMRX 的基金
- Rubric Capital Management LP 10.17M 股 · $176.02M · Q2 2026
- Nantahala Capital Management, LLC 2.27M 股 · $39.27M · Q2 2026
- Westshore Wealth, LLC 1.37M 股 · $23.65M · Q2 2026
- BlackBarn Capital Partners LP 1.30M 股 · $22.50M · Q2 2026
- Penn Capital Management Company, LLC 1.18M 股 · $20.48M · Q2 2026
- TUCKER ASSET MANAGEMENT LLC 1.01M 股 · $17.50M · Q2 2026
- Phocas Financial Corp. 819.48K 股 · $14.19M · Q2 2026
更多关于 TPG GP A, LLC
常见问题
How long has TPG GP A, LLC held AMRX?
TPG GP A, LLC has disclosed AMRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is TPG GP A, LLC's current position in AMRX?
As of Q2 2026, TPG GP A, LLC holds 12.33M shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $213.41M, representing 4.39% of its reported portfolio and ranking #7.
Has TPG GP A, LLC been buying or selling AMRX?
In the latest 13F filing (Q2 2026), TPG GP A, LLC held unchanged its position in AMRX. The position peaked in Q2 2026 at 12.33M shares.
Which other funds hold AMRX?
Other major institutional holders of AMRX include Rubric Capital Management LP, Nantahala Capital Management, LLC, Westshore Wealth, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.